Modulation of apoptosis by HIV protease inhibitors

被引:21
作者
Phenix, BN
Cooper, C
Owen, C
Badley, AD
机构
[1] Mayo Clin & Mayo Fdn, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[3] Ottawa Hlth Res Inst, Ottawa, ON, Canada
[4] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada
[5] Ottawa Hosp, Dept Med, Ottawa, ON, Canada
基金
加拿大健康研究院;
关键词
apoptosis; CD4 T cell; HIV; immunity; protease inhibitor;
D O I
10.1023/A:1016168411221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Advances in treatment have transformed the Human Immunodeficiency Virus (HIV) infection from a progressive and ultimately fatal disease to one that can be managed effectively by chronic suppressive antiretroviral therapy. The drugs now used to treat HIV infection not only inhibit viral replication but also have effects on cellular metabolism and homeostasis. Of particular interest to cellular immunologists, members of the HIV Protease Inhibitor (PI) class of antiretroviral agents possess intrinsic immunomodulatory and antiapoptotic properties. This review focuses on the development and use of PI together with their impact on HIV disease, immunity, and apoptosis.
引用
收藏
页码:295 / 312
页数:18
相关论文
共 210 条
[1]   Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis [J].
Adrie, C ;
Bachelet, M ;
Vayssier-Taussat, M ;
Russo-Marie, F ;
Bouchaert, I ;
Adib-Conquy, M ;
Cavaillon, JM ;
Pinsky, MR ;
Dhainaut, JF ;
Polla, BS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :389-395
[2]   EFFECT OF ITRACONAZOLE AND TERBINAFINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIDAZOLAM IN HEALTHY-VOLUNTEERS [J].
AHONEN, J ;
OLKKOLA, KT ;
NEUVONEN, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (03) :270-272
[3]   Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. [J].
Albrecht, MA ;
Bosch, RJ ;
Hammer, SM ;
Liou, SH ;
Kessler, H ;
Para, MF ;
Eron, J ;
Valdez, H ;
Dehlinger, M ;
Katzenstein, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :398-407
[4]   Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration [J].
Amendola, A ;
Poccia, F ;
Martini, F ;
Gioia, C ;
Galati, V ;
Pierdominici, M ;
Marziali, M ;
Pandolfi, F ;
Colizzi, V ;
Piacentini, M ;
Girardi, E ;
D'Offizi, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (02) :324-332
[5]   An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses [J].
André, P ;
Groettrup, M ;
Klenerman, P ;
de Giuli, R ;
Booth, BL ;
Cerundolo, V ;
Bonneville, M ;
Jotereau, F ;
Zinkernagel, RM ;
Lotteau, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13120-13124
[6]   INHIBITION OF APOPTOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS ENHANCES VIRUS PRODUCTION AND FACILITATES PERSISTENT INFECTION [J].
ANTONI, BA ;
SABBATINI, P ;
RABSON, AB ;
WHITE, E .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2384-2392
[7]   THE EFFECT OF ERYTHROMYCIN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOPICLONE [J].
ARANKO, K ;
LUURILA, H ;
BACKMAN, JT ;
NEUVONEN, PJ ;
OLKKOLA, KT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (04) :363-367
[8]  
Aries SP, 1998, SCAND J IMMUNOL, V48, P86, DOI 10.1046/j.1365-3083.1998.00347.x
[9]   A simple relationship between viral load and survival time in HIV-1 infection [J].
Arnaout, RA ;
Lloyd, AL ;
O'Brien, TR ;
Goedert, JJ ;
Leonard, JM ;
Nowak, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11549-11553
[10]   AN INHIBITOR OF THE PROTEASE BLOCKS MATURATION OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND SPREAD OF INFECTION [J].
ASHORN, P ;
MCQUADE, TJ ;
THAISRIVONGS, S ;
TOMASSELLI, AG ;
TARPLEY, WG ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7472-7476